• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio

    Frontage Bolsters Clinical Services Capabilities

    Sanofi Unveils EUROAPI as Name of New European API Company

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

    LSNE Expands Fill Finish and Lyophilization Ops
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Virtual Clinical Trials: The Future of Dermatology Studies

    Frontage Bolsters Clinical Services Capabilities

    Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane

    Adare Pharma Solutions

    Cytovance Biologics

    Flow Sciences

    Baxter BioPharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Adare Pharma Solutions

    Syngene

    Cytovance Biologics

    Aphena Pharma Solutions

    Reed-Lane
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    API Sourcing Trends

    Ed Price of PCI Synthesis addresses trends, regulatory and supply chain hurdles, and quality concerns

    API Sourcing Trends
    Ed Price of PCI Synthesis
    Related CONTENT
    • Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • MilliporeSigma Acquires AmpTec
    • Ajinomoto Bio-Pharma and Revance Therapeutics Partner
    • Aptar CSP Increases Capacity for Active Packaging Solutions
    Kristin Brooks, Contract Pharma03.19.15
    Globalization in the pharma and biopharma industry has contributed to an increasingly complex supply chain fraught with numerous challenges. And, outsourcing to emerging markets of India and China, for example, have led to increased regulatory scrutiny following numerous incidents of contaminated raw materials. Since then, APIs sourced from these, and other countries, have been subject to increased testing and regulatory inspections. Today, concerns about the supply chain and drug quality persist.
     
    PCI Synthesis, a manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, based in the greater Boston area, provides a domestic perspective.Contract Pharma spoke with Ed Price, the company’s president and chief executive officer, to discuss the latest API sourcing trends, regulatory and supply chain hurdles, and quality concerns. -KB
     
    Contract Pharma: What trends are you seeing with respect to API sourcing?
     
    Ed Price: Increasingly we see companies less interested in outsourcing to places like China and India. Companies that hoped to save their way to success have discovered they can save money overseas but they can’t guarantee they will get the right results. The FDA has heightened its level of regulatory scrutiny, holding overseas manufacturers to the same standards as those enforced in the U.S. But that will take time.
     
    Meanwhile, time zone hurdles, delivery timetables, occasional language barriers and the like, just make it more difficult for these companies to outsource overseas. By turning to a local manufacturer, they have the ability to forge a personal relationship, their issues can be addressed quickly, and they have the opportunity to closely monitor the quality of manufacturing on a continuous basis.

    CP: What types of product do you see an increased demand for? 

    EP: There is a steady demand for the manufacture of active ingredients, which is great for companies like PCI Synthesis, which specializes in this area. We also see a steady flow of new opportunities from smaller, virtual companies.
     
    CP: What are some of the main challenges clients approach PCI with?
     
    EP: Many clients who approach us have come to realize that their technology is not as advanced as they thought it was for clinical development. They are surprised at the level of investment, time and resources needed to get ready.
     
    CP: As a domestic supplier, how have continued challenges with India and China impacted your business?
     
    EP: Drugs or raw ingredients that come from overseas and found to be subpar hurt the entire industry. American consumers need to have faith that the medicines they are taking or giving to their children are of high quality and at the dosage their doctors’ recommend. 
     
    We’ve heard horror stories from our clients about their experiences overseas. Many of them have learned that lesson the hard way. When they work with us, we see first-hand how our culture, project management and quality products have a positive impact on them, their business and our business. As their contract manufacturer, we continually evaluate what we need to do to help our clients most effectively, independent of where they have been or where they might go in the future.
     
    CP: What do you anticipate in the near term as far as any progress in these regions? 
     
    EP: The FDA’s site inspections and increased scrutiny, coupled with oversees manufacturers’ improved adherence and compliance to the FDA’s regulations, will ultimately help the industry and the American public. But it is a slow road to travel, and it will be patchwork progress for a long while.
     
    CP: What are the major supply chain hurdles experienced today? How can they be overcome?
     
    EP: There is definitely a seasonal angle to supply chain hurdles. As all of us in the Northeast can probably tell you, the historic winter of 2015 impacted the supply chain in ways we had not seen before. Delivery delays were felt at every point in the supply chain. For PCI, for example, that translated in delays in raw materials that fortunately we were able to address in our production schedules. We were able to continue to deliver the high quality active ingredients and excellent service our clients expect of us because we were on top of the situation and communicated regularly and immediately with our clients. But the weather-induced delays wreaked havoc for other vendors, and for many it was a real struggle.
     
    Even when a hurdle is not tied to bad weather, delivery date slippage is a very real concern, particularly when the goods are coming from overseas. It takes a lot more work to manage those delivery delays when dealing with overseas suppliers; you don’t always get to the root of the real cause of the delays. Whether it is corruption, bad business models, inexperienced staff or something else, delays from overseas suppliers are just more challenging to deal with than delays you may find from U.S. suppliers.
     
    CP: How do you avoid interruptions, unexpected expenses, and quality control issues?
     
    EP: Every CMO can make its case on paper; but it is in the finer things – the day-to-day details – where a CMO really shows its value. We find that the project manager not only has to excel at delivering “the goods” but also has to ensure expectations are met and communication is effective and timely throughout the project lifecycle. Transparency, predictability and even chemistry all play a part in it. It’s important to always have a plan and a backup plan to avoid delays and interruptions, but more importantly, to keep customers in the loop at every stage, and have solid recommendations for any hurdles that we face. 
     
    CP: How do you help clients navigate increased legal and regulatory hurdles?
     
    EP: Staying on top of details is important in this business. But with increased competition, global outsourcing, higher levels of compliance and increasing regulation, those details are more complex than ever in this industry. You have to stay on top of what is coming down from the FDA, but also act immediately rather than defer until a later date. Also, it’s imperative to have ongoing, effective communication with our clients. We advise them on what the FDA is looking for and steer them in the right direction using our experience and best practices. The whole industry is very dynamic, and every company needs to be closely in tune to respond appropriately.
     
     
    Edward S. Price is a founding member of the New England CRO/CMO Council and the president of PCI, a 16-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products. He can be reached at Ed.Price@pcisynthesis.com.


    Kristin Brooks has been associate editor at Contract Pharma since 2004.
    Related Searches
    • Biopharma
    • CMO
    • API
    • Testing
    Suggested For You
    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact
    Baxter, Novavax Ink Sterile Manufacturing Agreement Baxter, Novavax Ink Sterile Manufacturing Agreement
    MilliporeSigma Acquires AmpTec MilliporeSigma Acquires AmpTec
    Ajinomoto Bio-Pharma and Revance Therapeutics Partner Ajinomoto Bio-Pharma and Revance Therapeutics Partner
    Aptar CSP Increases Capacity for Active Packaging Solutions Aptar CSP Increases Capacity for Active Packaging Solutions
    Thermo Fisher Expands Plasmid DNA Mfg. Capabilities  Thermo Fisher Expands Plasmid DNA Mfg. Capabilities
    Passage Bio Invests in Gene Therapy Manufacturing R&D Site Passage Bio Invests in Gene Therapy Manufacturing R&D Site
    Collaboration Creates Bio Hub in Northern UK Collaboration Creates Bio Hub in Northern UK
    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge
    ApiJect Systems Appoints General Counsel & Chief Compliance Officer ApiJect Systems Appoints General Counsel & Chief Compliance Officer
    Navigating Uncertainty: Considerations for Life Sciences 2021 Navigating Uncertainty: Considerations for Life Sciences 2021
    Passage Bio, Catalent Begin cGMP Mfg. for Gene Therapies Passage Bio, Catalent Begin cGMP Mfg. for Gene Therapies
    Schreiner MediPharm Joins DoseID Consortium Schreiner MediPharm Joins DoseID Consortium
    Catalent Appoints Minakuchi Facility GM Catalent Appoints Minakuchi Facility GM
    Thermo Fisher Scientific Further Expands Global Footprint Thermo Fisher Scientific Further Expands Global Footprint

    Related Online Exclusives

    • APIs | cGMP Manufacture | Chemistry | Cytotoxics and High Potency Manufacturing

      Patheon Furthers Expansion Strategy

      Patrick Glaser of Patheon discusses expanded manufacturing capacity, capabilities, and future plans
      Kristin Brooks, Contract Pharma 01.09.17

    • APIs | cGMP Manufacture | Chemistry | Drug Discovery | Process Development | Supply Chain

      API Sourcing Trends

      Drug product complexities, quality and regulatory hurdles drive market shift
      Kristin Brooks, Contract Pharma 04.11.16

    • Biosimilars | Chemistry | Fill/Finish
      Setting a Precedent for Biosimilars in the U.S.

      Setting a Precedent for Biosimilars in the U.S.

      Niall Dinwoodie of Charles River discusses several key industry issues on biosimilars and addresses some of the development and regulatory hurdles that remain
      Kristin Brooks, Contract Pharma 05.19.15


    • Analytical Services | Bioanalytical Services | Bioassay Development | Capsules | Chemistry | Clinical Trials | Drug Development | Excipients | Formulation Development | GMPs/GCPs | Industry News | Inspections | Laboratory Testing | Methods Development | Process Development | Regulatory Affairs | Solid Dosage/Semi-solids | Toxicology

      Molecular Profiles Hosts Bioavailability Event

      Biannual event attracts scientists, executives
      Gil Roth 02.11.14

    • Analytical Services | Bioanalytical Services | Bioassay Development | Chemistry | Laboratory Testing | Microbiology | Preclinical Outsourcing | Toxicology

      WIL Research Acquires Ricerca Lyon

      CEO David Spaight explains geographic, capacity play
      Gil Roth 08.26.13

    • Chemistry | Toxicology

      Ricerca Interview

      Ricerca CEO Ian Lennox discusses the acquisition of MDS Pharma Services
      Kristin Brooks 04.08.10


    • Chemistry | Drug Development

      Bringing it back to the States

      Does WuXi's acquisition of AppTec signal contract manufacturing's return to the US?
      Joanna Cosgrove 01.17.08

    • Chemistry | Clinical Trials | Drug Development | Drug Discovery

      India Report

      ...
      S. Harachand 07.23.07

    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Baxter, Novavax Ink Sterile Manufacturing Agreement
    • A New Era Of Vaccine And Biologic Drug Development
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    Breaking News
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    • Frontage Bolsters Clinical Services Capabilities
    • Sanofi Unveils EUROAPI as Name of New European API Company
    • Thermo Fisher Buys Novasep's Viral Vector Manufacturing Biz
    • Precision Medicine Group Acquires Project Farma
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    P&G, L'Oréal & Amorepacific Make News at CES
    Three Form Vertical Beauty Alliance
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login